Gallium 68 PET/CT Scanning for Neuroendocrine Tumors — Information and Locations (updated January 26, 2019)
NANETS Issues Position Statement on COVID-19 Vaccination for NET and NEC Patients
A growing body of evidence suggests that patients with cancer have an increased risk of severe COVID-19 infection and related complications. As such, NANETS, the North American Neuroendocrine Tumor Society, supports the plan for COVID-19 vaccination…
READ MORE
2020 Monica Warner Award: Call for Nominations
Advanced Accelerator Applications (AAA), a Novartis company, has announced that nominations are open for the 11th Annual Monica Warner Award! AAA is continuing the Novartis tradition of sponsoring the award, which commemorates the life and work of…
READ MORE
Understanding Patient Preferences in Neuroendocrine Tumor Treatments
When you meet with your healthcare team do you discuss what is important to you as you consider neuroendocrine tumor treatment options? You can help physicians better understand patient-centered treatment decision making by participating in this…
READ MORE
NANETS Webinar on COVID-19 for the Neuroendocrine Tumor Community
A panel of 10 neuroendocrine tumor (NET) medical experts will gather for an online conversation about COVID-19 and its impact on NET patients. Patients, families, and caregivers are invited to submit questions and panelists will answer as many as possible…
READ MORE
Progastrin, Novel Blood-Based Biomarker for Detection of Neuroendocrine Neoplasms
Clinicians and researchers at the University of Kentucky Division of Medical Oncology, College of Pharmacy, School of Medicine and Department of Surgical Oncology; ECS Progastrin in Switzerland; Centre Hospitalier Lyon-Sud in France; and Biospecimen…
READ MORE
2019 Monica Warner Award: Call for Nominations
Novartis has announced that nominations are open for the 10th Annual Monica Warner Award, which commemorates the life and work of Monica Warner as a driving force in the neuroendocrine tumor (NET) community. Nominations will be accepted until December…
READ MORE
Surgical Management of Neuroendocrine Tumors, November 21 Webinar for Patients and Caregivers
You’re invited to participate in a Neuroendocrine Tumor Awareness Month Webinar on November 21 from 7 to 9 pm, Eastern Time, presented by the American Association of Endocrine Surgeons (AAES). Four national experts will discuss the surgical management…
READ MORE
We SCAN! – INCA Launches First-Ever Global Survey to Measure Access Challenges to Optimal Neuroendocrine Tumor Care
In order to better understand the challenges of optimal care for neuroendocrine tumor (NET) patients, the International Neuroendocrine Cancer Alliance (INCA), of which the Carcinoid Cancer Foundation is a proud member, today launches SCAN –…
READ MORE
New York City Luncheon with the Experts on NET Cancer Day 2019
Join neuroendocrine tumor (NET) patients in New York City on Sunday, November 10, 2019 — NET Cancer Day — for a unique opportunity to have lunch with two medical experts. Share your experiences with others who have similar concerns and hear…
READ MORE
Let’s Talk About NET Survivorship: An Evening for Neuroendocrine Cancer Patients and Caregivers
“Let’s Talk About NET Survivorship!” is a special evening presentation on Friday, June 28 for neuroendocrine cancer patients and caregivers and their health care providers. Attend in person at the Grand Hotel Minneapolis in Minneapolis, Minnesota…
READ MORE